Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 3, Number 2—June 1997
Synopsis

Rhodococcus equi and Arcanobacterium haemolyticum: Two "Coryneform" Bacteria Increasingly Recognized as Agents of Human Infection

Regina LinderComments to Author 
Author affiliation: Hunter College, New York, New York, USA

Main Article

Table 2

Representative pharyngitis screenings for Arcanobacterium haemolyticum

Period of study (reference) Number of isolations Rash Coinfection Incidencea (%) Clinical features (population)
1978-80 (16) 16 0 13 (C. diphtheriae, S . pyogenes, E. coli, P. aeruginosa) NR Symptomatic throat swabs and pyoderma (Sri Lanka)
1981-85 (19) 81b 37 NR 2.0 Symptomatic throat swabs (Sweden)
1990-92 (17) 42 17 NR 0.36 Symptomatic throat swabs; 5 cases onospot
positive (Ottawa, Canada)
1991-92 (42) 19 5 11 (streptococci, groups A, B, G) 0.49 Symptomatic throat swabs,
3922c; (Finland)
1992-95 (43) 16 12 5 (streptococci, groups A, B, ß-hemolytic) 0.75 Symptomatic throat swabs,
2121c; (Czech Republic)

NR-not reported
a Incidence refers to the proportion of sore throat cases in each study cited yielding A. haemolyticum.
b1 of 550 asymptomatic specimens yielded A. haemolyticum.
cFigures refer to the total specimens screened.

Main Article

References
  1. Coyle  MB, Lipsky  BA. Coryneform bacteria in infectious diseases: clinical and laboratory aspects. Clin Microbiol Rev. 1990;3:227–46.PubMedGoogle Scholar
  2. McNeil  MM, Brown  JM. The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev. 1994;7:357–417.PubMedGoogle Scholar
  3. Magnusson  H. Spezifische infektioese Pneumonie beim Fohlen. Ein neuer Eitererreger beim Pferd. Archiv fur Wissenschaftliche und Praktische Tierheilkunde. 1923;50:22–37.
  4. Prescott  JF, Holmes  MA, Yager  JA, Takai  S, eds. Rhodococcus equi and immunology of the foal. Vet Microbiol. In press.
  5. Prescott  JF. Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev. 1991;4:20–34.PubMedGoogle Scholar
  6. Takai  S, Sasaki  Y, Ikeda  T, Uchida  Y, Tsubaki  S, Sekizaki  T. Virulence of Rhodococcus equi isolates from patients with and without AIDS. J Clin Microbiol. 1994;32:457–60.PubMedGoogle Scholar
  7. Scott  MA, Graham  BS, Verall  R, Dixon  R, Schaffner  W, Tham  KT. Rhodococcus equi-an increasingly recognized opportunistic pathogen. Am J Clin Pathol. 1995;103:649–55.PubMedGoogle Scholar
  8. Doig  C, Gill  MJ, Church  DL. Rhodococcus equi-an easily missed opportunistic pathogen. Scand J Infect Dis. 1991;23:1–6. DOIPubMedGoogle Scholar
  9. Harvey  RL, Sunstrum  JC. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis. 1991;13:139–45.PubMedGoogle Scholar
  10. Linder  R. Rhodococcus equi: an emerging opportunist in humans. PHLS Microbiology Digest. 1994;11:87–91.
  11. Verville  TD, Huycke  MM, Greenfiled  RA, Fine  DP, Kuhls  TL, Slater  LN. Rhodococcus equi infections in humans. Medicine. 1994;73:119–32. DOIPubMedGoogle Scholar
  12. Sutor  GC, Fibich  C, Kirschner  P, Kuske  M, Schmidt  RE, Schedel  I, Poststenotic cavitating pneumonia due to Rhodococcus equi in HIV infection. AIDS. 1996;10:339–40. DOIPubMedGoogle Scholar
  13. Donisi  A, Suardi  MG, Casari  S, Longo  M, Cadeo  GP, Carosi  G. Rhodococcus equi infection in HIV-infected patients. AIDS. 1996;10:359–62. DOIPubMedGoogle Scholar
  14. MacLean  PD, Liebow  AA, Rosenberg  AA. A hemolytic corynebacterium resembling Corynebacterium ovis and Corynebacterium pyogenes in man. J Infect Dis. 1946;79:69–90.
  15. Collins  MD, Jones  D, Schofield  GM. Reclassification of Corynebacterium haemolyticum in the genus Arcanobacterium gen. nov. as Arcanobacterium haemolyticum nom.rev.,comb.nov. J Gen Microbiol. 1982;128:1279–81.PubMedGoogle Scholar
  16. Wickremesinghe  RSB. Corynebacterium haemolyticum infections in Sri Lanka. Journal of Hygiene-Cambridge. 1981;87:271–7. DOIGoogle Scholar
  17. Mackenzie  A, Fuite  LA, Chan  FTH, King  J, Allen  A, MacDonald  N, Incidence and pathogenicity of Arcanobacterium haemolyticum during a 2-year study in Ottawa. Clin Infect Dis. 1995;21:177–81.PubMedGoogle Scholar
  18. Green  SL, LaPeter  KS. Pseudodiphtheritic membranous pharyngitis caused by Corynebacterium hemolyticum. JAMA. 1981;:2330–1. DOIPubMedGoogle Scholar
  19. Banck  G, Nyman  M. Tonsilitis and rash associated with Corynebacterium haemolyticum. J Infect Dis. 1986;154:1037–40.PubMedGoogle Scholar
  20. Gaston  DA, Zurowski  SM. Arcanobacterium haemolyticum pharyngitis exanthem. Arch Dermatol. 1996;132:61–4. DOIPubMedGoogle Scholar
  21. Fraser  G. The effect on animal erythrocytes of combinations of diffusible substances produced by bacteria. J Pathol Bacteriol. 1964;88:43–58. DOIPubMedGoogle Scholar
  22. Nordmann  P, Nicolas  MH, Gutmann  L. Penicillin-binding proteins of Rhodococcus equi: potential role in resistance to imipenem. Antimicrob Agents Chemother. 1993;37:1406–9.PubMedGoogle Scholar
  23. Nordmann  P, Zinzendorf  N, Keller  M, Lair  I, Ronco  E, Guenounou  M. Interaction of virulent and non-virulent Rhodococcus equi human isolates with phagocytes, fibroblast- and epithelial-derived cells. FEMS Immunol Med Microbiol. 1994;9:199–206. DOIPubMedGoogle Scholar
  24. Hietala  SK, Ardans  AA. Interaction of Rhodococcus equi with phagocytic cells from R. equi-exposed and non-exposed foals. Vet Microbiol. 1987;14:307–20. DOIPubMedGoogle Scholar
  25. Hondalus  MK, Mosser  DM. Survival and replication of Rhodococcus equi in macrophages. Infect Immun. 1994;62:4167–75.PubMedGoogle Scholar
  26. Zink  MC, Yager  JA, Prescott  JF, Fernando  MA. Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages. Vet Microbiol. 1987;14:295–305. DOIPubMedGoogle Scholar
  27. Gotoh  K, Mitsuyama  M, Imaizumi  S, Yano  I. Mycolic acid-containing glycolipid as a possible virulence factor of Rhodococcus equi for mice. Microbiol Immunol. 1991;35:175–85.PubMedGoogle Scholar
  28. Takai  S, Madarame  H, Matsumoto  C, Inoue  M, Sasaki  Y, Hasegawa  Y, Pathogenesis of Rhodococcus equi infection in mice: roles of virulence plasmids and granulomagenic activity of bacteria. FEMS Immunol Med Microbiol. 1995;11:181–90. DOIPubMedGoogle Scholar
  29. Tkachuk-Saad  O, Prescott  J. Rhodococcus equi plasmids: isolation and partial characterization. J Clin Microbiol. 1991;29:2696–700.PubMedGoogle Scholar
  30. Linder  R, Bernheimer  AW. Enzymatic oxidation of membrane cholesterol in relation to lysis of sheep erythrocytes by corynebacterial enzymes. Arch Biochem Biophys. 1982;213:395–404. DOIPubMedGoogle Scholar
  31. Linder  R, Bernheimer  AW. Cytotoxicity of Rhodococcus equi related to generation of cholestenone in macrophage and erythrocyte membranes. Vet Microbiol. In press.
  32. Kanaly  ST, Hines  SA, Palmer  GH. Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect Immun. 1996;64:1126–32.PubMedGoogle Scholar
  33. Kanaly  ST, Hines  SA, Palmer  GH. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect Immun. 1995;63:3037–41.PubMedGoogle Scholar
  34. Delia  S, Mastroianni  CM, Lichtener  M, Mengoni  F, Moretti  S, Vullo  V. Defective production of interferon-gamma and tumour necrosis factor-alpha by AIDS mononuclear cells after in vitro exposure to Rhodo-coccus equi. Mediators Inflamm. 1995;4:306–9. DOIPubMedGoogle Scholar
  35. Mastroianni  CM, Lichtner  M, Vullo  V, Delia  S. Humoral immune response to Rhodococcus equi in AIDS patients with R. equi pneumonia. J Infect Dis. 1994;169:1179–80.PubMedGoogle Scholar
  36. Soucek  A, Michalec  C, Souckova  A. Identification and characterization of a new enzyme of the group "phos-pholipase D" isolated from Corynebacterium ovis. Biochim Biophys Acta. 1971;227:116–28.PubMedGoogle Scholar
  37. Cuevas  WA, Songer  JG. Arcanobacterium haemolyticum phospholipase D is genetically and functionally similar to Corynebacterium pseudotuberculosis phospholipase D. Infect Immun. 1993;61:4310–6.PubMedGoogle Scholar
  38. McNamara  PJ, Bradley  GA, Songer  JG. Targetted mutagenesis of the phospholipase D gene results in decreased virulence of Corynebacterium pseudotu-berculosis. Mol Microbiol. 1994;12:921–30. DOIPubMedGoogle Scholar
  39. Bernheimer  AW, Campbell  BJ, Forrester  LJ. Com-parative toxinology of Loxosceles reclusa and Corynebacterium pseudotuberculosis. Science. 1985;228:590–1. DOIPubMedGoogle Scholar
  40. McNeil  MM, Brown  JM. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens. Eur J Epidemiol. 1992;8:437–43. DOIPubMedGoogle Scholar
  41. Nordmann  P. Antimicrobial susceptibility of human isolates of Rhodococcus equi. Med Microbiol Lett. 1995;4:277–86.
  42. Carlson  P, Renoken  OV, Kotainen  S. Arcanobacterium haemolyticum and streptococcal pharyngitis. Scand J Infect Dis. 1994;26:283–7. DOIPubMedGoogle Scholar
  43. Chalupa  P, Jezek  P, Jurankova  J, Sevcikova  A. Isolation of Arcanobacterium haemolyticum from throat culture samples in the Czech Republic. Infection. 1995;23:397. DOIPubMedGoogle Scholar

Main Article

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external